Navigation Links
DIA Conference to Explore Components of Risk Management Plans As They Apply to Medicinal Products, Therapeutic Biologics and Vaccines
Date:11/5/2009

Expert speakers from industry, Health Canada, EMEA, FDA, and PMDA will lead presentations at the 2nd DIA Conference on Harmonization of Risk Management Plans to be held December 10-11, 2009 in Washington, DC.

Horsham, PA (Vocus) November 5, 2009 -- Expert speakers from industry, Health Canada, EMEA, FDA, and PMDA will lead presentations at the 2nd DIA Conference on Harmonization of Risk Management Plans to be held December 10-11, 2009 in Washington, DC.

This conference will explore the essential components of RMP as they apply to medicinal products, therapeutic biologics, and vaccines with a focus on real and potential risks of products, which may be made available to patients and healthcare providers in different regions of the world. Sessions will include:

 
  • Risk Management Plans: What Do They Mean and What Are the Requirements for Each Region?
  • Risk Management Plans: What Have We Learned from RMPs About Managing Product Risks?
  • Developing an Harmonized Risk Management Plan
  • Successes and Opportunities for Harmonized Risk Management Plans
  • Risk Management Plans Town Meeting
  • Future Developments of RMPs and REMS
“The 2nd DIA Conference on Harmonization of Risk Management Plans will bring together global regulators and industry representatives to lead hands-on exercises and didactic presentations and to participate in panel discussions,” explains Program Chair William W. Gregory, Director, Safety and Risk Management, Pfizer Inc. “They will discuss why RMPs are important to your organization from a global regulatory perspective, the pros and cons of a global vs. local approach to developing RMPs, how an harmonized RMP can promote efficient, evidence-based decision-making to support the best use of marketed products, and how to develop an harmonized approach to creating an RMP.”

Register for the 2nd DIA Conference on Harmonization of Risk Management Plans.

About the Drug Information Association (DIA):
A non-profit, neutral, multidisciplinary, global, member-driven association, DIA serves more than 30,000 professionals involved in the biopharmaceutical industry, academia, research organizations and governmental bodies worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of drug development and medical product lifecycle management. DIA is led by its volunteer Board of Directors and executive management team, has headquarters in Horsham, PA, USA, and offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China. For more information, visit www.diahome.org or call 215-442-6100.

Contact:
Joe Krasowski
DIA
+1-215-293-5812

###

Read the full story at http://www.prweb.com/releases/2009/11/prweb3163264.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
5. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
7. AtriCure to Present at Roth Capital Partners 2007 New York Conference
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. MDS to Present at Thomas Weisel Partners Healthcare Conference
10. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
11. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
DIA Conference to Explore Components of Risk Management Plans As They Apply to Medicinal Products, Therapeutic Biologics and Vaccines
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology: